This episode of Dr. Gilbert Hosts is generously supported by Acorda Therapeutics and Genentech.
APDA’s Chief Scientific Officer, Dr. Rebecca Gilbert speaks with special guest Kathleen Poston, MD, Movement Disorders Specialist at Stanford University, for a conversation about the cognitive effects of Parkinson’s disease.
For your convenience, we’ve broken down the session by timecode, so you can skip or revisit sections and questions that interest you most. Simply fast-forward the video to the time indicated below:
02:17 Dr. Poston introductory presentation
24:03 What is the difference between Parkinson’s disease dementia, Dementia with Lewy bodies, and
Lewy body dementia?
28:14 Are there mental or physical exercises that can slow cognitive decline?
31:08 Are there any medications or supplements that can slow cognitive decline?
33:04 Can Deep brain stimulation (DBS) help cognition? Hurt cognition?
35:34 Young-onset PD and cognition
37:41 Is there a role for diet in slowing cognitive decline?
40:19 What guidance do you give your patients who are having cognitive issues?
43:10 Should I get cognitive testing as a baseline before I have cognitive symptoms?
44:28 Does COVID or the COVID vaccine have any effect on cognition in PD?
48:30 Is there any reason for hope or encouragement regarding the future of cognition and PD?
51:27 Hallucinations, cognition and PD
54:38 Apathy, cognition and PD
56:47 Is there a role for music in helping cognition?
Subscribe to this RU-vid channel for more and connect with APDA at:
www.apdaparkinson.org
apdaparkinsons
apdaparkinsons
apdaparkinsons
www.linkedin.com/company/apdaparkinsons
1 мар 2021
